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Insulin resistance and obesity are underlying causesof type 2 diabetes and therefore much interest is
focused on the potential genes involved. A series of
anthropometric and metabolic characteristic were
measured in 240 MZ and 112 DZ twin pairs recruited
from the East Flanders Prospective Twin Survey.
Microsatellite markers located close to ABCC8,
ADIPOQ, GCK, IGF1, IGFBP1, INSR, LEP, LEPR, PPARγ
and the RETN gene were genotyped. Univariate single
point variance components linkage analyses were per-
formed using two methods: (1) the standard method,
only comprising the phenotypic and genotypic data of
the DZ twin pairs and (2) the extended method, also
incorporating the phenotypic data of the MZ twin
pairs. Suggestive linkages (LOD > 1) were observed
between the ABCC8 marker and waist-to-hip ratio and
HDL-cholesterol levels. Both markers flanking ADIPOQ
showed suggestive linkage with triglycerides levels,
the upstream marker also with body mass and HDL-
cholesterol levels. The IGFBP1 marker showed
suggestive linkage with fat mass, fasting insulin and
leptin levels and the LEP marker showed suggestive
linkage with birth weight. This study suggests that
DNA variants in ABCC8, ADIPOQ, IGFBP1 and LEP
gene region may predispose to type 2 diabetes. In
addition, the two methods used to perform linkage
analyses yielded similar results. This was however not
the case for birth weight where chorionicity seems to
be an important confounder.
Keywords: East Flanders Prospective Twin Survey, Type 2
diabetes, Obesity, Dyslipidaemia, Linkage, Candidate Genes
Type 2 diabetes is a complex disorder that represents a
major international public health threat (O’Rahilly et
al., 2005). Although lifestyle factors play a prominent
role in the development of the disease, the high preva-
lence of type 2 diabetes in specific ethnic groups and
the much higher concordance rates of traits associated
with the disorder in monozygotic (MZ) twins com-
pared to dizygotic (DZ) twins indicate that genetic
predisposition is also important (Krosnick, 2000;
Souren et al., 2007). To uncover genes involved in
type 2 diabetes, numerous genome-wide linkage scans
have been carried out and evidence for linkage at
several chromosomal regions has been reported (Arya
et al., 2002; Loos et al., 2003; Rankinen et al., 2006).
Usually, these regions are large and contain many
genes and therefore candidate genes in subsequent
studies are often selected based on pre-existing knowl-
edge. Currently, much interest is focused on genes
involved in insulin resistance and obesity, since these
two intertwined factors are considered to be underly-
ing causes of type 2 diabetes (Golay & Ybarra, 2005;
Grundy, 2006).
In the condition of insulin resistance, normal insulin
concentrations fail to trigger a normal metabolic
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response. To resist diabetes, pancreatic beta cells then
need to overcompensate with sufficient insulin release
(Saltiel, 2001).
Pancreatic beta cells produce and secrete insulin
mainly in response to blood glucose, which is taken up
into the cells through the glucose transporter isotype 2
(GLUT2) and subsequently phosphorylated into
glucose-6-phosphate by glucokinase (GCK) (Kulkarni,
2004; Saltiel, 2001). This metabolic activity in the
pancreatic beta cell leads to an increase in the
ATP/ADP ratio and closure of the ATP-sensitive potas-
sium (KATP) channel, which is composed of the inward
rectifying K+ channel (Kir6.2) and the sulfonylurea
receptor (SUR1; encoded by ABCC8). The closure is
followed by membrane depolarization, which activates
voltage gated calcium channels and leads to intracellu-
lar Ca2+ rise triggering insulin secretion (Ashcroft,
2005; Yan et al., 2004).
In addition to insulin there are also other hor-
mones with insulin-like effects. The most important of
these is insulin-like growth factor 1 (IGF1), which is
the second most powerful peptide with glucose lower-
ing effects (Janssen & Lamberts, 2002). The effects of
insulin and IGF1 on carbohydrate, lipid and protein
metabolism are mediated by their receptors (INSR,
IGF1R). Insulin and IGF1 are able to bind to each
others receptor, although the affinity is considerably
lower (Bluher et al., 2005). IGF1 circulates almost
entirely bound to one of the six members of the IGF
binding proteins (IGFBPs) family. Although the major-
ity of IGF1 is bound to IGFBP3, IGFBP1 has been
suggested to be the short-term regulator of IGF1
bioactivity and is negatively associated with risk
factors of cardiovascular disease and positively with
insulin sensitivity (Heald et al., 2001; Janssen &
Lamberts, 2002; Lee et al., 1997).
Obesity, another major factor underlying type 2
diabetes, is defined as excess accumulation of adipose
tissue. Adipose tissue, formerly considered to be an
inert energy depository, is now also known as an
important endocrine organ producing active molecules
called adipocytokines including adiponectin, leptin
and resistin, which are encoded by ADIPOQ, LEP
and RETN, respectively (Gil-Campos et al., 2004).
Increased adiponectin levels are associated with weight
loss and increased insulin sensitivity (Koerner et al.,
2005; Meier & Gressner, 2004). Additionally, in pre-
pubertal children, adiponectin is negatively associated
with plasma lipid markers, except for HDL-cholesterol
that shows a positive relation (Gil-Campos et al.,
2004). Leptin, which biological activities are carried
out through selective binding to its receptor (LEPR), is
mainly produced by adipocytes, but also expressed in
other tissues including placenta, ovaries, skeletal
muscle, stomach, pituitary and liver (Koerner et al.,
2005; Paracchini et al., 2005). Leptin acts as a satiety
signal affecting central circuits in the hypothalamus
resulting in suppressed food intake and increased
energy expenditure (Koerner et al., 2005). Furthermore
peripheral leptin seems to play a role in controlling cel-
lular lipid balance, glucose homeostasis and insulin
sensitivity (Koerner et al., 2005; Muoio & Lynis
Dohm, 2002). Resistin has been linked to insulin resis-
tance in murine models (Gil-Campos et al., 2004;
Koerner et al., 2005). In humans, however, the rela-
tionship between resistin and markers of the metabolic
syndrome is still controversial (Koerner et al., 2005;
Meier & Gressner, 2004; Rea & Donnelly, 2004).
Besides secreting active molecules adipose tissue has
the capacity to expand drastically during life (Bluher et
al., 2005), which is correlated with many unfavourable
side effects. Therefore the role of proteins such as the
peroxisome proliferator-activated receptor γ (PPARγ)
and IGF1, which among other processes regulate fat
cell formation and functioning, are also of great inter-
est in the pathology of obesity (Bluher et al., 2005;
Gurnell, 2005).
Previously we estimated the heritability of 18
anthropometric and metabolic characteristics associ-
ated with type 2 diabetes measured in 378 healthy twin
pairs recruited from the East Flanders Prospective Twin
Survey (EFPTS) (Souren et al., 2007). In general, heri-
tability estimates of the traits studied in our twin
sample were high. In order to explain some of the
genetic variance observed, we performed univariate
single point variance components linkage analyses
using microsatellite markers located within or near
candidate genes including ABCC8, ADIPOQ, GCK,
IGF1, IGFBP1, INSR, LEP, LEPR, PPARγ and
RETN. Linkage to metabolic traits in these candidate
gene regions provides evidence for the possible pres-
ence of genetic variation in that region influencing
these traits and is an incentive for further fine mapping
the region. Several software packages are available to
carry out sib-pair based variance components linkage
analyses. The statistical package Mx is especially
designed to analyse twin data (Neale et al., 2002), but
another commonly used program is MERLIN
(Abecasis et al., 2002). The advantage of Mx compared
to MERLIN is that Mx also incorporates the pheno-
typic data of the MZ twins. This allows to partition the
total variation into effects due to the quantitative trait
locus (QTL; Q), additive genetic (A), nonadditive
genetic (D), or common environmental (C) and unique
environmental effects (E), resulting in a very accurate
estimation of the variance components. In addition,
when the distribution of a trait differs among men and
women it is possible to model these sex differences by
using a scalar model. By comparing the fit-functions of
the different models one can assess which model pro-
vides the best fit to the data and use that model to
conduct the linkage analysis. MERLIN, on the contrary
simply incorporates the phenotypic and genotypic data
of the DZ twins and decomposes the total phenotypic
variance into effects due to the QTL (Q), additive
genetic factors (A) and unique environmental factors
(E). In the present study, sib-pair variance component
linkage analyses were conducted using both the
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‘MERLIN method’, which we call the standard
method, and the ‘Mx method’, which we call the
extended method.
Materials and Methods
Subjects
The EFPTS is a population-based twin register, which
started in 1964 and has been recording all multiple
births in the Belgian Province of East Flanders until
the present (Loos et al., 1998). For the current study, a
series of anthropometric and metabolic phenotypes of
378 complete twin pairs were available, divided over
138 DZ pairs (46 male, 49 female and 43 mixed pairs)
and 240 MZ pairs (113 male and 127 female pairs).
Since not all participants were willing to provide
DNA, DNA was available from 288 complete twin
pairs comprising 112 DZ pairs (34 male, 43 female
and 35 mixed pairs) and 176 MZ pairs (78 male and
98 female pairs). In the present analysis, if genotypic
data were absent then the phenotypic data could only
be used if the twins were MZ. As a result, in the
current analysis phenotypic data of 352 complete
pairs were used, divided over 112 DZ pairs and 240
MZ pairs, of which 138 pairs were monochorionic
(MC) and 102 were dichorionic (DC). Birth weights
were obtained from obstetric records, and gestational
age reported by the obstetrician was calculated as the
number of completed weeks of pregnancy based on
the last menstrual period. The methods used to
measure the phenotypes at adult age and a detailed
description of the twin sample has been described
earlier (Loos et al., 1998; Souren et al., 2007). The
Ethics Committee of the Faculty of Medicine of the
Katholieke Universiteit Leuven approved the project
and all participants gave informed consent.
DNA Extractions and Marker Selection
Genomic DNA was extracted initially from available
placental tissue collected at birth. If placental tissue
was unavailable, twin pairs were contacted and whole
blood or mouth swabs were taken for DNA extrac-
tion. The DNA mini kit (Qiagen) was used for
placental and mouth swab DNA extraction, the
Wizard kit (Promega) was used for blood DNA
extraction, both according to manufacturer’s instruc-
tions. Microsatellite markers (di- and tetranucleotide
repeats) were selected from the human UniSTS map
(http://www.ncbi.nlm.nih.gov/genome/sts). Markers
were chosen based on distance to the candidate gene
and level of heterozygosity. The location of the
markers and candidate genes as well as marker het-
erozygosity is presented in Table 1.
Polymerase Chain Reactions (PCRs)
Ten PCR protocols were used to amplify 14 markers of
10 candidate genes. Six markers could be optimized to
fit in two multiplexed PCR protocols (multiplex 1:
markers D3S1602, GCK, D7S2427 and D1S198; mul-
tiplex 2: markers D3S3686 and D11S902) and the
others were amplified in singleplex PCR protocols.
Primer sequences including fluorescent labels, MgCl2
concentrations, PCR annealing temperature and the
number of cycles are listed in Table 1. Further PCR
ingredients (15 or 20 µl) consisted of 1x PCR buffer
(Invitrogen, Breda, the Netherlands), 0.33 mM dNTPs
(GE Healthcare, Eindhoven, the Netherlands), 4-8
pmol primers (Eurogentec, Seraing, Belgium), 5%
DMSO and 0.5-1 U Taq DNA polymerase (Invitrogen).
All PCRs were performed in Biometra T1 thermal
cyclers (Westburg, Leusden, the Netherlands), starting
with an initial denaturation at 95°C for 5 min and
ending with a final extension of 10 min at 72°C.
Genotyping
All TET-labeled PCR products were diluted 10 times,
FAM-labeled products 5-10 times and HEX-labeled
products 0-5 times. Labeled fragments were size-
resolved by capillary electrophoresis on the ABI3100
Genetic Analyzer and size calling was performed with
Genescan Software version 3.7 (Applied Biosystems,
Nieuwerkerk a/d IJssel, the Netherlands). The TAMRA
350-size standard was used for fragment length calling.
Two experienced researchers scored the final genotypes
independently and a third expert was consulted for dis-
crepant results.
General Statistical Analysis
Anthropometric and metabolic characteristics are
expressed as mean ± SD. Traits with a skewed distrib-
ution were converted to a normal distribution by log
transformation. Differences between men and women
according to zygosity were tested using the PROC
MIXED method, in which adjustment for the intra-
twin pair relationship was possible. Differences were
considered significant if p < .05. For all traits effects of
potential covariates were also checked using PROC
MIXED, which has been described in detail before
(Souren et al., 2007). General statistical analysis were
conducted using the statistical package SAS (version
9.1, SAS Institute).
Linkage Analysis
A χ2-test was used to check Hardy-Weinberg equilib-
rium for genotype frequencies of the microsatellite
markers, using only one randomly selected co-twin
per pair (using genotypes of MZ and DZ twin pairs).
To test for linkage between marker loci and the
anthropo metric and metabolic characteristics, univari-
ate single point variance components linkage analyses
were performed using the statistical package Mx
(Neale et al., 2002). The script was downloaded from
the GenomEUtwin Mx-script library (http://www.psy.
vu.nl/mxbib/). Linkage analysis was performed with
and without adjusting for significant covariates. In
addition we compared two methods: (1) standard sib-
pair variance components linkage analysis, only
comprising the phenotypic and genotypic data of the
DZ twin pairs and (2) extended sib-pair variance
components linkage analysis, also incorporating the
phenotypic data of the MZ twin pairs. In the standard
method the phenotypic variation is decomposed into
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variance due to the QTL (Q), additive genetic factors
(A) and unique environmental factors (E). In the
extended method, the phenotypic data of the MZ
twin pairs were also included, having the advantage
of partitioning the phenotypic variance into effects
due to the QTL (Q), additive genetic (A), nonadditive
genetic (D), or common environmental (C) and
unique environmental effects (E). For the latter
method, optimisation of the univariate model of the
different phenotypes has been carried out. A detailed
description of this optimisation procedure has been
reported elsewhere (Souren et al., 2007), and a short
summary is presented in columns 2, 3 and 16 of Table
4. Our sample size is too small to conduct sex-specific
linkage analyses, therefore we used a scalar model
(allowing the total variances to differ between men
and women) for the traits (BMI, body mass, fat body
mass) that had a model with different variance com-
ponents estimates for men and women as the best
fitting model (Souren et al., 2007). In the unadjusted
analysis sex effects were not modeled. In these
instances only simple univariate models without
scalar sex effects were used. For birthweight the intra-
pair correlations differ between MZ MC and MZ DC
twins. Since data on chorionicity were available,
extended variance component linkage analysis for
birth weight was performed in three different ways:
(1) using only phenotypic data of MZ DC twins, (2)
using only phenotypic data of MZ MC twins, and (3)
incorporating phenotypic data of both MZ MC and
MZ DC twins.
Estimates of the variance component associated
with the QTL were obtained using the pi-hat
approach, in which the covariance due to the marker
or QTL for a sib-pair is modelled as a function of the
proportion of alleles shared identical by descent (IBD).
Since parental data were not available, the probabili-
ties of sharing 0, 1 or 2 alleles IBD were estimated in
MERLIN (Abecasis et al., 2002) using allele frequen-
cies based on one randomly selected co-twin per pair
(using genotypes of MZ and DZ twin pairs). The
effect of the QTL was evaluated by comparing a full
model, in which the genetic variance caused by Q for
a given phenotype was free, with a restricted model, in
which the effect of Q was equal to zero. Logarithm of
the odds (LOD) scores, computed as the difference in
–2log likelihood divided by 4.6, were used to evaluate
the QTL effect. Because we used a candidate gene
approach, the multiple testing problem associated
with genome-wide search does not apply (Lander &
Kruglyak, 1995). Suggestive evidence for linkage was
defined by LOD>1 and significant evidence for linkage
by LOD>3.
Results
General Statistical Analysis
In Table 2 anthropometric and metabolic characteris-
tics of the MZ and DZ twins are expressed as mean ±
SD according to sex. In both MZ and DZ twins, men
had a higher body height, body mass, WHR, lean body
mass and fasting glucose levels, but lower sum of four
skinfolds, fat mass, IGFBP1, fasting insulin, leptin,
total cholesterol, HDL-cholesterol and non-esterified
fatty acids levels than women (p < .05). In DZ twins
only, men had a higher weight at birth (p < .05).
Linkage Analysis
Microsatellite markers D7S2427 (GCK) and D7S478
(IGFBP1) deviated from the assumptions of Hardy-
Weinberg equilibrium (p < .05) and were excluded
from further linkage analyses.
Results of the univariate single-point variance
component linkage analysis performed using the stan-
dard and the extended method, unadjusted and
adjusted for significant covariates are listed in Table 3
and Table 4. After adjustment, the D11S902 (ABCC8)
marker showed suggestive linkage with WHR, and
with HDL-cholesterol levels using the extended
method only. Before adjustment, linkage with HDL-
cholesterol levels was nonsignificant. The D3S1602
(ADIPOQ) marker showed in the adjusted analysis
suggestive linkage with body mass and HDL-choles-
terol levels using both methods, and with triglycerides
levels using the extended method only. Before control-
ling for covariates linkage with triglycerides levels was
nonsignificant and suggestive linkage with body height
and lean body mass was observed. The downstream
marker D3S3686 showed also suggestive linkage with
triglycerides levels using both methods, while before
adjustment this linkage was nonsignificant and linkage
with HDL-cholesterol levels seemed suggestive.
After controlling for covariates, the D7S2506
marker (IGFBP1) showed suggestive linkage with
leptin levels using both methods, with fat mass using
the standard method only and with fasting insulin
using the extended method only. Before adjusting, this
marker showed also suggestive linkage with the sum
of four skinfolds, and with fat mass it showed signifi-
cant linkage.
After adjustment, the D7S530 (LEP) marker
showed suggestive linkage with birth weigh using the
standard method only. Before controlling for covari-
ates, also suggestive linkage with fasting insulin levels
was observed.
The D1S2638 (LEPR) and the D19S1034 (INSR)
marker showed in the unadjusted analysis suggestive
linkage with IGFBP1 and with fasting glucose levels,
respectively. However, after adjustment these linkages
became nonsignificant.
Discussion
In the current study, a series of anthropometric and
metabolic characteristics were measured in 240 MZ
and 112 DZ twin pairs recruited from the EFPTS.
Fourteen microsatellite markers located within 10 can-
didate gene regions were genotyped and univariate
single point variance components linkage analyses were
performed. The initial DZ twin sample comprises 138
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twin pairs, of which 26 DZ twin pairs did not provide
DNA. As differences in mean age (25.4 vs. 25.7),
weight (65.1 vs. 65.8) and height (172.1 vs. 172.1) are
negligible between the two samples, the genotyped
sample is still representative for the initial DZ twin
sample. Two microsatellite markers, one located near
GCK (D7S2427) and the other near IGFBP1
(D7S478), deviated from the assumptions of Hardy-
Weinberg equilibrium (HWE). Deviation from HWE
can occur due to genotyping errors, inbreeding,
genetic drift, selection and population stratification.
Because the last four causes have impact on the whole
genome and in the current study only 2 of the 14
markers deviated from HWE, the most likely reason
for deviation from HWE is genotyping errors, presum-
ably systematic mistyping of heterozygotes as
homozygotes (Gomes et al., 1999). To avoid false pos-
itive linkage results, these markers were excluded from
further linkage analyses.
Linkage analyses were carried out unadjusted as
well as adjusted for significant covariates, resulting in
considerable differences between the linkage results
(Table 3 and Table 4). In many occasions, unadjusted
LOD scores were larger than 1 and gave therefore sug-
gestive evidence for linkage, but after adjusting for
covariates LOD scores were non-significant. The
D7S2506 marker (IGFBP1) for example showed sug-
gestive linkage with the sum of four skinfolds (LODS =
2.03; LODE = 2.19) in the unadjusted analysis, but
after adjusting for sex and age the LOD scores were
non-significant (LODS = 0.74; LODE = 0.66). The
opposite also occurred, where LOD scores were
smaller than 1 in the unadjusted analysis, but gave
suggestive evidence for linkage after controlling for
significant covariates. For example, linkage with the
D3S3686 marker (ADIPOQ) and triglycerides levels
was not significant in the unadjusted analysis (LODS =
0.60; LODE = 0.63), but after adjusting for covariates
linkage was suggestive (LODS = 1.09; LODE = 1.42).
These data indicate that controlling for covariates has
great impact on the final linkage results and without
adjustment false positive and false negative outcomes
are eminent and may lead to futile follow up studies.
In the present study DNA was only available of
112 DZ twin pairs, and consequently our power to
detect QTLs is rather low. In addition, we recognise
that due to the large number of statistical tests per-
formed some of the results reported here may
represent false–positive findings and therefore our
results must be interpreted cautiously. Nevertheless,
five of the 12 microsatellite markers located in four
candidate gene regions (ABCC8, ADIPOQ, IGFBP1
and LEP) showed after adjusting for covariates sug-
gestive linkage with several anthropometric and
metabolic characteristics. The D11S902 marker close
510 Twin Research and Human Genetics October 2008
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Table 2
Anthropometric and Metabolic Characteristics of the MZ and DZ Twins According to Sex
MZ DZ
Characteristic Men Women p Men Women p
N 226 254 104 120
Gestational age (wks)a 36.8 ± 2.33 37.0 ± 2.59 0.33 37.4 ± 2.3 37.5 ± 2.2 .77
Birth weight (g) 2531 ± 471 2451 ± 485 0.17 2694 ± 472 2581 ± 470 .005
Age (yrs)a 25.2 ± 4.6 25.1 ± 4.6 0.83 25.1 ± 4.6 25.5 ± 4.6 .54
Body height (cm) 178.1 ± 6.3 165.2 ± 6.2 < .0001 178.5 ± 6.6 166.7 ± 6.5 < .0001
Body mass (kg) 70.3 ± 9.7 60.5 ± 10.1 < .0001 70.1 ± 10.0 60.8 ± 9.6 < .0001
BMI (kg/m2)b 22.0 ± 1.1 21.9 ± 1.2 0.97 21.9 ± 1.1 21.7 ± 1.1 .87
WHR (%) 83.4 ± 5.5 73.4 ± 4.6 < .0001 82.6 ± 5.4 72.2 ± 4.1 < .0001
Sum of four skin folds (mm)b 35.4 ± 1.5 56.4 ± 1.4 < .0001 33.9 ± 1.1 52.3 ± 1.4 < .0001
Fat mass (kg)b 11.6 ± 1.5 16.8 ± 1.3 < .0001 12.1 ± 1.5 16.6 ± 1.3 < .0001
Lean body mass (kg) 57.7 ± 6.5 43.0 ± 5.3 < .0001 56.9 ± 6.6 43.6 ± 5.8 < .0001
IGFBP1 (ng/ml)b 10.7 ± 1.9 16.7 ± 2.1 < .0001 11.9 ± 1.9 18.5 ± 2.2 < .0001
Fasting insulin (pmol/l)b 33.2 ± 1.5 37.3 ± 1.6 0.02 32.0 ± 1.6 40.8 ± 1.5 .0001
Fasting glucose (mmol/l) 5.0 ± 0.4 4.5 ± 0.4 < .0001 4.8 ± 0.4 4.6 ± 0.4 .0001
Leptin (ng/ml)b 1.6 ± 2.9 11.4 ± 2.1 < .0001 1.6 ± 2.8 11.6 ± 1.9 < .0001
Total cholesterol (mmol/l) 4.8 ± 1.0 5.1 ± 0.9 0.0008 4.9 ± 1.1 5.2 ± 0.9 .03
LDL-cholesterol (mmol/l) 3.0 ± 0.9 2.9 ± 0.8 0.54 3.1 ± 1.0 2.9 ± 0.8 .06
HDL-cholesterol (mmol/l) 1.3 ± 0.3 1.8 ± 0.4 < 0.0001 1.4 ± 0.4 1.9 ± 0.4 < .0001
Triglycerides (mmol/l)b 0.9 ± 1.5 0.9 ± 1.5 0.32 0.9 ± 1.5 0.9 ± 1.3 .85
Non-esterified fatty acids (mmol/l) 0.5 ± 0.2 0.7 ± 0.2 < .0001 0.5 ± 0.2 .7 ± 0.2 < .0001
Note: Data are expressed as mean ± SD; ap-value calculated using standard linear regression, because convergence criteria could not be met in the random intercept model;
bGeometric mean ± SD.
to the ABCC8 gene showed suggestive linkage with
WHR and HDL-cholesterol levels. 4.5 kb downstream
of ABCC8, the KCNJ11 gene encoding the other
subunit of the KATP channel (Kir6.2) is located. This
gene contains the E23K single nucleotide polymor-
phism (SNP), which is a well-established genetic risk
factor for type 2 diabetes and which is in strong
linkage disequilibrium with the coding SNP A1369S
(rs757110) in exon 33 of ABCC8 (Florez et al., 2004;
Scott et al., 2007). However, the E23K SNP has been
genotyped in our twin sample and association analysis
revealed that this SNP did not explain the observed
linkage signal (data not shown). This indicates that
besides the KCNJ11 E23K SNP, also other genetic
variants predisposing to type 2 diabetes are located in
the ABCC8 gene region. For example, SNPs in the
promoter of ABCC8 that have in a Finnish sample
been associated with an increased type 2 diabetes risk
(Laukkanen et al., 2004). Nevertheless, the linkage
signal might also be the consequence of rare popula-
tion specific variants.
The D3S1602 marker, upstream the ADIPOQ
gene, showed evidence for suggestive linkage with body
mass, HDL-cholesterol and triglycerides levels. The
D3S3686 marker, located downstream of ADIPOQ,
also showed linkage with triglycerides levels, suggest-
ing that a genetic variant close to the markers
influences this particular trait. Several genome wide
scans reported evidence for linkage with the 3q27 locus
and anthropometric and metabolic characteristics
(Kissebah et al., 2000; Luke et al., 2003; Pollin et al.,
2005). Moreover, a genome-wide linkage scan of
plasma adiponectin levels in the Amish Family
Diabetes Study reported the highest LOD score
between markers D3S1602 and D3S1580, which also
flank the ADIPOQ gene, as in our study (Pollin et al.,
2005). Several polymorphisms in ADIPOQ have
already been associated with circulating adiponectin
levels, obesity, insulin resistance and cardiovascular
disease risk (Bouatia-Naji et al., 2006; Gable et al.,
2007; Hara et al., 2002; Menzaghi et al., 2002; Pollin
et al., 2005; Qi et al., 2006; Sutton et al., 2005;
Vasseur et al., 2006). However, more type 2 diabetes
candidate genes are located in the ADIPOQ gene
region and accordingly the observed linkage signals
might also be the result of genetic variation in one of
these other genes. For example, the somatostatin (SST)
gene which is in the close vicinity of the D3S3686
marker, and the diacylglycerol kinase gamma (DGKG)
gene or the insulin-like growth factor 2 mRNA binding
protein 2 (IGF2BP2) gene that are located near the
D3S1602 marker.
The D7S2506 marker located in the IGFBP1 gene
region showed suggestive linkage with fat mass,
fasting insulin and leptin levels. Until now, just one
genome wide linkage scan reported suggestive linkage
with this region (D7S1818; LOD = 2.20) and trends in
BMI from childhood to adulthood (Chen et al., 2004).
Probably as a consequence, only few association
studies with IGFBP1 have been carried out. Ukkola et
al. (2001) reported association with an intronic SNP
and overfeeding induced changes in abdominal vis-
ceral fat, OGTT (oral glucose tolerance test) insulin
area and total cholesterol levels in twins, and a coding
SNP (A4403G) has been associated with impaired
renal function in type 2 diabetes (Stephens et al.,
2005). Although IGFBP1 has not been studied very
intensively, our linkage results and the strong pheno-
typic correlation of IGFBP1 levels with other
metabolic risk factors suggest an interesting role of the
IGFBP1 gene in the development of the metabolic
syndrome (Heald et al., 2001; Wolk et al., 2004). The
fact that we did not observe linkage between the
D7S2506 marker and IGFBP1 levels is remarkable.
However, in a genome wide linkage analysis using
expression phenotypes, more trans-acting QTLs than
cis-acting QTLs (mapped within 5Mb of the target
gene) were observed (Morley et al., 2004). This indi-
cates that even gene expression levels are complex
traits and transcription regulators are not by defini-
tion closely located to the gene. In addition, it should
be noted that the IGFBP1 gene is located closely to
the IGFBP3 gene, and therefore IGFBP3 could also be
responsible for the observed linkage signal.
The D7S530 marker located near the LEP gene
(7q32.2) showed suggestive linkage with birthweight.
Linkage of the 7q32.3 locus with birthweight has, as
far as we know, not been reported previously. How -
ever, a growth-promoting role for leptin during fetal
development has been suggested before (Domali &
Messinis, 2002), because umbilical cord leptin levels
are positively correlated with birthweight (Schulz et
al., 2000). Moreover, we recently showed that two
polymorphisms in the leptin receptor (LEPR) gene
predispose to a higher weight at birth (Souren et al.,
2008). Interestingly, in the present study the two
microsatellite markers located near the LEPR gene
showed no linkage with birthweight. To detect a QTL
for a complex trait like birthweight, which is con-
trolled by many loci with small effects, association
studies are more powerful than linkage studies. Hence,
linkage signals are probably not the result of one poly-
morphism, but represent a joint effect of several
(common and rare) variants.
In the literature the GCK, IGF1, INSR, LEP,
LEPR, PPARγ and RETN gene regions have been
associated with type 2 diabetes or traits related to this
disease (Rankinen et al., 2006). In the current study
we did not detect linkage with traits related to type 2
diabetes and markers located within these gene
regions. This does not imply that these regions do not
contribute to the development of type 2 diabetes in the
current sample, but the studied sample or the contri-
bution of these loci to the traits may be too small to
detect them in this linkage study.
We compared two methods when performing uni-
variate single point variance components linkage
analysis. The standard method comprised only pheno-
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typic and genotypic data of the DZ twin pairs and is
therefore equal to the sib-pair based variance compo-
nent linkage analysis implemented in MERLIN
(Abecasis et al., 2002). In the extended method, which
is implemented in Mx (Neale et al., 2002), the pheno-
typic data of the MZ twin pairs were also incorporated
and model fitting was carried out to obtain the best-
fitting model. This results in a more accurate
estimation of the variance components compared to
the standard method. Despite the differences between
the two methods used, they gave fairly similar linkage
results. However, for fasting insulin, of which the vari-
ance is partly explained by nonadditive genetic factors
(DE model), LOD scores were remarkably higher using
the extended method compared to the standard
method (see Table 3 and Table 4). This might be the
result of the low DZ twin correlations, because when
non-additive genetic factors are present DZ twin corre-
lations are less than half of the MZ twin correlations.
In the standard method the size of the genetic compo-
nent is estimated based on data of DZ twins only, and
we observed that the size of the genetic component in
the standard method was lower than in the extended
method. Our data might suggest that the underestima-
tion of the genetic effect size in the standard method
also results in an underestimation of the QTL effect.
This indicates, that when nonadditive genetic factors
are present the extended method is more powerful
than the standard method. However, nonadditive
genetic factors also explain part of the variance of
IGFBP1 levels and for this trait LOD scores were not
consistently higher using the extended method.
Moreover, our sample size and the number of micro -
satellite markers tested are limited, and therefore these
results should be interpreted carefully.
We also performed linkage analyses with birth
weight. Because MZ MC twins suffer a more adverse
intrauterine environment than MZ DC twins, intra-pair
correlations for birthweight are significantly lower for
MZ MC compared to MZ DC twins. Since the EFPTS
has data on chorionicity available, we were able to
compare four different methods for birthweight: (1) the
standard method, (2) the extended method incorporat-
ing only phenotypic data of MZ DC twins, (3) the
extended method incorporating only phenotypic data
of MZ MC twins, and (4) the extended method in
which phenotypic data of both MZ MC and MZ DC
were incorporated (see Tables 3 and 4). In general, the
four methods gave similar results, except for the
D7S530 marker that showed suggestive linkage using
the standard method (LODSunadjusted = 1.13, LODSadjusted =
1.02) and the extended method in which only the phe-
notypic data of the MZ DC twins were incorporated
(LODE(MZDConly)unadjusted = 1.12, LODE(MZDConly)adjusted = 0.97).
However, LOD scores for the D7S530 marker were
considerably lower in the methods incorporating phe-
notypic data of the MZ MC twins (LODE(MZMConly)unadjusted
= 0.41, LODE(MZMConly)adjusted = 0.26; LODEunadjusted = 0.78,
LODEadjusted = 0.63). Probably due to the low covariance
of the MZ MC twins, the size of the genetic effect and
consequently the QTL effect was underestimated. This
suggests that including phenotypic data of MZ MC
twins results in a reduced power to detect a QTL for
birth weight using variance component linkage analy-
ses. In addition, these results indicate that when
chorionicity is an important confounder and data on
chorionicity is unavailable, variance component
linkage analysis should be performed using data of
DZ twins only.
Although the sample size and the number of
microsatellite markers tested in the present study are
limited, our data suggest that genetic variation located
in the ABCC8, ADIPOQ, IGFBP1 and LEP gene
regions influence anthropometric and metabolic char-
acteristics in the East Flanders twin sample. In
addition, our data shows that carrying out sib-pair
based variance components linkage analyses by either
using advanced modelling in Mx or using the straight-
forward standard method implemented in the
MERLIN package yield similar results, at least when
chorionicity is not an important confounder.
Acknowledgments
This work was financially supported by the Dutch
Diabetes Research Foundation (DFN 2002.00.15) and
the National Fund for Scientific Research Belgium
(G.0383.03; G.3.0269.97). The EFPTS has been partly
supported by grants from Funds of Scientific Research
Flanders and by the Association for Scientific
Research in Multiple Births (Twins vzw). We are
grateful to all twins participating in this study. We
thank Ingeborg Berckmoes, Annie Roossens, Lut De
Zeure, Margaret Van Heuverswyn and An Voets for
fieldwork and technical assistance. We thank Prof. dr.
Martine Thomis for reviewing our manuscript.
References
Abecasis, G. R., Cherny, S. S., Cookson, W. O., & Cardon,
L. R. (2002). Merlin: Rapid analysis of dense genetic
maps using sparse gene flow trees. Nature Genetics, 30,
97–101.
Arya, R., Blangero, J., Williams, K., Almasy, L., Dyer, T.
D., Leach, R. J., O’Connell, P., Stern, M. P., &
Duggirala, R. (2002). Factors of insulin resistance syn-
drome: Related phenotypes are linked to genetic
locations on chromosomes 6 and 7 in nondiabetic
Mexican–Americans. Diabetes, 51, 841–847.
Ashcroft, F. M. (2005). ATP-sensitive potassium chan-
nelopathies: Focus on insulin secretion. Journal of
Clinical Investigation, 115, 2047–2058.
Bluher, S., Kratzsch, J., & Kiess, W. (2005). Insulin-like
growth factor I, growth hormone and insulin in white
adipose tissue. Best Practice and Research: Clinical
Endocrinology and Metabolism, 19, 577–587.
Bouatia-Naji, N., Meyre, D., Lobbens, S., Seron, K.,
Fumeron, F., Balkau, B., Heude, B., Jouret, B., Scherer,
P. E., Dina, C., Weill, J., & Froguel, P. (2006).
512 Twin Research and Human Genetics October 2008
Nicole Y. Souren et al.
513Twin Research and Human Genetics October 2008
Linkage of Metabolically ‘Thrifty’ Genes in the EFPTS
Ta
bl
e 
3
Re
su
lts
 (L
OD
 S
co
re
s)
 o
f U
ni
va
ria
te
 S
in
gl
e-
Po
in
t V
ar
ia
nc
e 
Co
m
po
ne
nt
s 
Li
nk
ag
e 
An
al
ys
es
 U
na
dj
us
te
d 
fo
r S
ig
ni
fic
an
t C
ov
ar
ia
te
s 
Pe
rfo
rm
ed
 U
si
ng
 th
e 
St
an
da
rd
 (S
) a
nd
 th
e 
Ex
te
nd
ed
 (E
) M
et
ho
d
AB
CC
8
AD
IP
OQ
GC
K
IG
F1
IG
FB
P1
IN
SR
LE
P
LE
PR
PP
AR
γ
RE
TN
Tr
ai
t
M
et
ho
d
M
od
el
D1
1S
90
2
D3
S1
60
2
D3
S3
68
6
GC
K
IG
F1
D7
S2
50
6
D1
9S
10
34
D7
S5
30
D1
S2
63
8
D1
S1
98
D3
S1
26
3
D1
9S
41
3
Bi
rth
 w
ei
gh
t
S
0.
00
0.
00
0.
15
0.
00
0.
00
0.
21
0.
11
1.
13
0.
00
0.
07
0.
13
0.
52
E M
ZD
Co
nl
y
AC
E
0.
00
0.
03
0.
61
0.
00
0.
00
0.
19
0.
01
1.
12
0.
00
0.
00
0.
27
0.
39
E M
ZM
Co
nl
y
AC
E
0.
00
0.
02
0.
31
0.
00
0.
00
0.
11
0.
01
0.
41
0.
00
0.
01
0.
13
0.
30
E
AC
E
0.
00
0.
03
0.
56
0.
00
0.
00
0.
18
0.
01
0.
78
0.
00
0.
00
0.
24
0.
43
Bo
dy
 h
ei
gh
t
S
0.
46
1.
33
0.
67
0.
03
0.
00
0.
00
0.
00
0.
06
0.
00
0.
16
0.
03
0.
00
E
AE
0.
51
1.
17
0.
60
0.
06
0.
00
0.
00
0.
00
0.
09
0.
00
0.
10
0.
02
0.
00
Bo
dy
 m
as
s
S
0.
11
2.
07
0.
20
0.
00
0.
00
0.
00
0.
00
0.
08
0.
53
0.
00
0.
50
0.
00
E
AE
0.
15
1.
98
0.
16
0.
00
0.
00
0.
00
0.
00
0.
04
0.
60
0.
00
0.
32
0.
00
BM
I
S
0.
00
0.
47
0.
07
0.
00
0.
00
0.
49
0.
00
0.
11
0.
11
0.
00
0.
41
0.
00
E
AE
0.
00
0.
56
0.
08
0.
00
0.
00
0.
76
0.
00
0.
20
0.
00
0.
00
0.
62
0.
00
W
HR
S
1.
02
0.
21
0.
19
0.
28
0.
00
0.
00
0.
00
0.
32
0.
10
0.
00
0.
00
0.
00
E
AE
1.
39
0.
05
0.
09
0.
23
0.
00
0.
00
0.
00
0.
29
0.
34
0.
00
0.
00
0.
00
Su
m
 o
f f
ou
r s
ki
n 
fo
ld
s
S
0.
00
0.
58
0.
29
0.
00
0.
00
2.
03
0.
00
0.
00
0.
00
0.
01
0.
00
0.
00
E
AE
0.
00
0.
53
0.
29
0.
00
0.
00
2.
19
0.
00
0.
00
0.
00
0.
04
0.
00
0.
00
Fa
t m
as
s
S
0.
00
0.
88
0.
27
0.
00
0.
00
3.
64
0.
00
0.
00
0.
44
0.
00
0.
54
0.
00
E
AE
0.
00
1.
00
0.
24
0.
00
0.
00
3.
53
0.
00
0.
00
0.
22
0.
00
0.
53
0.
00
Le
an
 b
od
y 
m
as
s
S
0.
56
1.
56
0.
70
0.
00
0.
00
0.
00
0.
00
0.
06
0.
45
0.
21
0.
05
0.
00
E
AE
0.
61
1.
34
0.
66
0.
01
0.
00
0.
00
0.
00
0.
06
0.
49
0.
17
0.
03
0.
00
IG
FB
P1
S
0.
00
0.
03
0.
10
0.
02
0.
25
0.
11
0.
00
0.
00
1.
00
0.
00
0.
01
0.
00
E
DE
0.
00
0.
03
0.
13
0.
06
0.
25
0.
12
0.
00
0.
04
1.
12
0.
00
0.
03
0.
04
Fa
st
in
g 
in
su
lin
S
0.
30
0.
00
0.
00
0.
00
0.
00
0.
97
0.
00
1.
09
0.
59
0.
09
0.
00
0.
00
E
DE
0.
60
0.
02
0.
04
0.
19
0.
22
1.
28
0.
03
1.
43
0.
86
0.
35
0.
00
0.
01
Fa
st
in
g 
gl
uc
os
e
S
0.
00
0.
00
0.
00
0.
11
0.
00
0.
17
0.
92
0.
30
0.
00
0.
00
0.
00
0.
48
E
AE
0.
00
0.
00
0.
00
0.
12
0.
00
0.
16
1.
04
0.
32
0.
00
0.
00
0.
00
0.
42
Le
pt
in
S
0.
00
0.
06
0.
00
0.
01
0.
00
0.
88
0.
01
0.
07
0.
07
0.
39
0.
05
0.
00
E
AE
0.
00
0.
03
0.
00
0.
04
0.
00
1.
21
0.
03
0.
04
0.
06
0.
49
0.
05
0.
00
To
ta
l c
ho
le
st
er
ol
S
0.
05
0.
03
0.
00
0.
00
0.
05
0.
01
0.
18
0.
00
0.
04
0.
07
0.
00
0.
01
E
AC
E
0.
03
0.
03
0.
00
0.
00
0.
18
0.
00
0.
14
0.
00
0.
13
0.
11
0.
00
0.
04
LD
L-
ch
ol
es
te
ro
l
S
0.
23
0.
00
0.
00
0.
00
0.
19
0.
00
0.
03
0.
00
0.
00
0.
02
0.
00
0.
00
E
AC
E
0.
37
0.
00
0.
00
0.
00
0.
70
0.
00
0.
00
0.
00
0.
19
0.
14
0.
00
0.
00
HD
L-
ch
ol
es
te
ro
l
S
0.
84
2.
95
2.
49
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
19
E
AE
0.
92
2.
96
2.
42
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
22
Tr
ig
ly
ce
rid
es
S
0.
00
0.
79
0.
60
0.
49
0.
00
0.
34
0.
04
0.
18
0.
01
0.
00
0.
56
0.
00
E
AE
0.
00
0.
84
0.
63
0.
41
0.
00
0.
37
0.
04
0.
19
0.
00
0.
00
0.
57
0.
00
N
on
-e
st
er
ifi
ed
 fa
tty
 a
ci
ds
S
0.
68
0.
06
0.
16
0.
00
0.
44
0.
00
0.
00
0.
00
0.
21
0.
02
0.
00
0.
00
E
AE
0.
63
0.
04
0.
13
0.
00
0.
38
0.
00
0.
00
0.
00
0.
20
0.
02
0.
00
0.
00
N
ot
e:
Bo
ld
 a
nd
 u
nd
er
lin
ed
 n
um
be
rs
: L
OD
>1
 a
nd
 L
OD
<3
 s
ug
ge
st
iv
e 
ev
id
en
ce
 fo
r l
in
ka
ge
; L
OD
>3
 s
ig
ni
fic
an
t e
vi
de
nc
e 
fo
r l
in
ka
ge
.S
: s
ta
nd
ar
d 
m
et
ho
d,
 E
: e
xt
en
de
d 
m
et
ho
d,
 E
M
ZD
Co
nl
y:o
nl
y 
ph
en
ot
yp
ic
 d
at
a 
of
 M
Z 
DC
 tw
in
s 
w
er
e 
in
co
rp
or
at
ed
, E
M
ZM
Co
nl
y:o
nl
y 
ph
en
ot
yp
ic
da
ta
 o
f M
Z 
M
C 
tw
in
s 
w
er
e 
in
co
rp
or
at
ed
.
514 Twin Research and Human Genetics October 2008
Nicole Y. Souren et al.
Ta
bl
e 
4
Re
su
lts
 (L
OD
 S
co
re
s)
 o
f U
ni
va
ria
te
 S
in
gl
e-
Po
in
t V
ar
ia
nc
e 
Co
m
po
ne
nt
s 
Li
nk
ag
e 
An
al
ys
es
 A
dj
us
te
d 
fo
r S
ig
ni
fic
an
t C
ov
ar
ia
te
s 
Pe
rfo
rm
ed
 U
si
ng
 th
e 
St
an
da
rd
 (S
) a
nd
 th
e 
Ex
te
nd
ed
 (E
) M
et
ho
d
AB
CC
8
AD
IP
OQ
GC
K
IG
F1
IG
FB
P1
IN
SR
LE
P
LE
PR
PP
AR
γ
RE
TN
Tr
ai
t
M
et
ho
d
M
od
el
D1
1S
90
2
D3
S1
60
2
D3
S3
68
6
GC
K
IG
F1
D7
S2
50
6
D1
9S
10
34
D7
S5
30
D1
S2
63
8
D1
S1
98
D3
S1
26
3
D1
9S
41
3
Co
va
ria
te
s
Bi
rth
 w
ei
gh
t
S
0.
00
0.
02
0.
20
0.
04
0.
00
0.
07
0.
03
1.
02
0.
00
0.
00
0.
32
0.
61
Se
x,
 g
es
ta
tio
na
l 
E M
ZD
Co
nl
y
AC
E
0.
00
0.
02
0.
23
0.
03
0.
00
0.
06
0.
03
0.
97
0.
00
0.
00
0.
37
0.
57
ag
e
E M
ZM
Co
nl
y
AC
E
0.
00
0.
02
0.
13
0.
00
0.
00
0.
07
0.
02
0.
26
0.
00
0.
00
0.
16
0.
35
E
AC
E
0.
00
0.
02
0.
25
0.
01
0.
00
0.
08
0.
03
0.
63
0.
00
0.
00
0.
31
0.
58
Bo
dy
 h
ei
gh
t
S
0.
00
0.
95
0.
14
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
06
0.
67
0.
00
Se
x,
 a
ge
E
AE
0.
00
0.
86
0.
11
0.
00
0.
00
0.
01
0.
00
0.
00
0.
00
0.
07
0.
66
0.
00
Bo
dy
 m
as
s
S
0.
00
1.
59
0.
00
0.
00
0.
00
0.
41
0.
00
0.
02
0.
56
0.
00
0.
52
0.
00
Se
x,
 a
ge
, h
ei
gh
t
E 
AE
a
0.
00
1.
50
0.
01
0.
00
0.
00
0.
29
0.
00
0.
05
0.
24
0.
00
0.
35
0.
00
BM
I
S
0.
00
0.
47
0.
05
0.
00
0.
00
0.
50
0.
00
0.
16
0.
12
0.
00
0.
41
0.
00
Ag
e
E
AE
a
0.
00
0.
50
0.
09
0.
00
0.
00
0.
47
0.
00
0.
42
0.
00
0.
00
0.
33
0.
00
W
HR
S
1.
02
0.
01
0.
00
0.
37
0.
00
0.
00
0.
00
0.
59
0.
02
0.
00
0.
03
0.
00
Se
x,
 a
ge
E
AE
a
1.
09
0.
00
0.
00
0.
48
0.
00
0.
00
0.
00
0.
68
0.
09
0.
00
0.
01
0.
00
Su
m
 o
f f
ou
r s
ki
n 
fo
ld
s
S
0.
00
0.
53
0.
29
0.
00
0.
00
0.
74
0.
00
0.
00
0.
03
0.
00
0.
00
0.
00
Se
x,
 a
ge
E
AE
a
0.
00
0.
71
0.
36
0.
00
0.
00
0.
66
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
Fa
t m
as
s
S
0.
00
0.
67
0.
21
0.
01
0.
02
1.
20
0.
00
0.
13
0.
18
0.
00
0.
41
0.
00
Se
x,
 a
ge
E
AE
a
0.
00
0.
75
0.
20
0.
05
0.
00
0.
85
0.
00
0.
23
0.
12
0.
00
0.
46
0.
00
Le
an
 b
od
y 
m
as
s
S
0.
03
0.
97
0.
05
0.
00
0.
00
0.
02
0.
00
0.
04
0.
16
0.
00
0.
02
0.
00
Se
x,
 a
ge
, h
ei
gh
t
E
AE
a
0.
00
0.
92
0.
00
0.
00
0.
00
0.
14
0.
00
0.
01
0.
27
0.
00
0.
09
0.
00
IG
FB
P1
S
0.
00
0.
02
0.
26
0.
09
0.
08
0.
20
0.
00
0.
00
0.
56
0.
00
0.
01
0.
00
Se
x,
 a
ge
, B
M
I
E
DE
a
0.
00
0.
01
0.
40
0.
09
0.
07
0.
13
0.
00
0.
00
0.
55
0.
00
0.
04
0.
03
Fa
st
in
g 
in
su
lin
S
0.
11
0.
05
0.
05
0.
00
0.
00
0.
76
0.
00
0.
29
0.
46
0.
07
0.
00
0.
00
Ag
e,
 S
4S
F
E
DE
0.
31
0.
18
0.
28
0.
11
0.
16
1.
13
0.
07
0.
66
0.
70
0.
31
0.
00
0.
00
Fa
st
in
g 
gl
uc
os
e
S
0.
00
0.
00
0.
00
0.
19
0.
00
0.
17
0.
91
0.
10
0.
00
0.
00
0.
05
0.
23
Se
x,
 B
M
I
E
AE
a
0.
00
0.
00
0.
00
0.
28
0.
00
0.
08
0.
70
0.
16
0.
00
0.
00
0.
11
0.
09
Le
pt
in
S
0.
01
0.
37
0.
15
0.
02
0.
34
1.
54
0.
00
0.
00
0.
18
0.
00
0.
00
0.
00
Se
x,
 a
ge
, S
4S
F
E
AE
a
0.
00
0.
36
0.
22
0.
32
0.
12
1.
42
0.
00
0.
00
0.
21
0.
00
0.
00
0.
00
To
ta
l c
ho
le
st
er
ol
S
0.
02
0.
00
0.
00
0.
00
0.
28
0.
00
0.
09
0.
00
0.
12
0.
30
0.
00
0.
11
Ag
e,
 S
4S
F
E
AE
0.
03
0.
00
0.
00
0.
00
0.
04
0.
00
0.
15
0.
00
0.
00
0.
12
0.
00
0.
04
LD
L-
ch
ol
es
te
ro
l
S
0.
07
0.
00
0.
00
0.
04
0.
43
0.
00
0.
05
0.
00
0.
14
0.
22
0.
00
0.
00
Se
x,
 a
ge
, S
4S
F
E
AE
0.
02
0.
00
0.
00
0.
06
0.
05
0.
00
0.
10
0.
00
0.
00
0.
06
0.
00
0.
00
HD
L-
ch
ol
es
te
ro
l
S
0.
93
1.
83
0.
57
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
48
Se
x,
 S
4S
F
E
AE
a
1.
09
1.
88
0.
70
0.
00
0.
01
0.
00
0.
00
0.
00
0.
00
0.
00
0.
00
0.
47
Tr
ig
ly
ce
rid
es
S
0.
00
1.
00
1.
09
0.
73
0.
00
0.
45
0.
02
0.
00
0.
00
0.
00
0.
28
0.
00
Se
x,
 S
4S
F
E
AE
0.
00
1.
15
1.
42
0.
58
0.
00
0.
64
0.
04
0.
00
0.
00
0.
00
0.
17
0.
00
N
on
-e
st
er
ifi
ed
 fa
tty
 a
ci
ds
S
0.
28
0.
16
0.
15
0.
00
0.
27
0.
00
0.
01
0.
00
0.
19
0.
02
0.
00
0.
00
Se
x,
 S
4S
F
E
AE
a
0.
21
0.
05
0.
13
0.
00
0.
27
0.
00
0.
00
0.
00
0.
18
0.
01
0.
00
0.
00
N
ot
e:
Bo
ld
 a
nd
 u
nd
er
lin
ed
 n
um
be
rs
: L
OD
 >
 1
 s
ug
ge
st
iv
e 
ev
id
en
ce
 fo
r l
in
ka
ge
. S
: s
ta
nd
ar
d 
m
et
ho
d,
 E
: e
xt
en
de
d 
m
et
ho
d,
 E
M
ZD
Co
nl
y:o
nl
y 
ph
en
ot
yp
ic
 d
at
a 
of
 M
Z 
DC
 tw
in
s 
w
er
e 
in
co
rp
or
at
ed
, E
M
ZM
Co
nl
y:o
nl
y 
ph
en
ot
yp
ic
 d
at
a 
of
 M
Z 
M
C 
tw
in
s 
w
er
e 
in
co
rp
or
at
ed
. a
 S
ca
la
r
ef
fe
ct
.
ACDC/Adiponectin Polymorphisms are associated
with severe childhood and adult obesity. Diabetes, 55,
545–550.
Chen, W., Li, S., Cook, N. R., Rosner, B. A., Srinivasan,
S. R., Boerwinkle, E., & Berenson, G. S. (2004). An
autosomal genome scan for loci influencing longitudi-
nal burden of body mass index from childhood to
young adulthood in white sibships: The Bogalusa
Heart Study. International Journal of Obesity and
Related Metabolic Disorders, 28, 462–469.
Domali, E., & Messinis, I. E. (2002). Leptin in pregnancy.
Journal of Maternal-Fetal and Neonatal Medicine, 12,
222–230.
Florez, J. C., Burtt, N., de Bakker, P. I., Almgren, P.,
Tuomi, T., Holmkvist, J., Gaudet, D., Hudson, T. J.,
Schaffner, S. F., Daly, M. J., Hirschhorn, J. N., Groop,
L., & Altshuler, D. (2004). Haplotype structure and
genotype-phenotype correlations of the sulfonylurea
receptor and the islet ATP-sensitive potassium channel
gene region. Diabetes, 53, 1360–1368.
Gable, D. R., Matin, J., Whittall, R., Cakmak, H., Li, K.
W., Cooper, J., Miller, G. J., & Humphries, S. E.
(2007). Common adiponectin gene variants show dif-
ferent effects on risk of cardiovascular disease and type
2 diabetes in European subjects. Annals of Human
Genetics, 71, 453–466.
Gil-Campos, M., Canete, R. R., & Gil, A. (2004).
Adiponectin, the missing link in insulin resistance and
obesity. Clinical Nutrition, 23, 963–974.
Golay, A., & Ybarra, J. (2005). Link between obesity and
type 2 diabetes. Best Practice and Research: Clinical
Endocrinology and Metabolism, 19, 649–663.
Gomes, I., Collins, A., Lonjou, C., Thomas, N. S.,
Wilkinson, J., Watson, M., & Morton, N. (1999).
Hardy-Weinberg quality control. Annals of Human
Genetics, 63, 535–538.
Grundy, S. M. (2006). Drug therapy of the metabolic
syndrome: minimizing the emerging crisis in poly -
pharmacy. Nature Reviews: Drug Discovery, 5,
295–309.
Gurnell, M. (2005). Peroxisome proliferator-activated
receptor gamma and the regulation of adipocyte func-
tion: Lessons from human genetic studies. Best
Practice and Research: Clinical Endocrinology and
Metabolism, 19, 501–523.
Hara, K., Boutin, P., Mori, Y., Tobe, K., Dina, C., Yasuda,
K., Yamauchi, T., Otabe, S., Okada, T., Eto, K.,
Kadowaki, H., Hagura, R., Akanuma, Y., Yazaki, Y.,
Nagai, R., Taniyama, M., Matsubara, K., Yoda, M.,
Nakano, Y., Tomita, M., Kimura, S., Ito, C., Froguel,
P., & Kadowaki, T. (2002). Genetic variation in the
gene encoding adiponectin is associated with an
increased risk of type 2 diabetes in the Japanese popu-
lation. Diabetes, 51, 536–540.
Heald, A. H., Cruickshank, J. K., Riste, L. K., Cade, J. E.,
Anderson, S., Greenhalgh, A., Sampayo, J., Taylor, W.,
Fraser, W., White, A., & Gibson, J. M. (2001). Close
relation of fasting insulin-like growth factor binding
protein-1 (IGFBP-1) with glucose tolerance and car-
diovascular risk in two populations. Diabetologia, 44,
333–339.
Janssen, J. A., & Lamberts, S. W. (2002). The role of IGF-
I in the development of cardiovascular disease in type
2 diabetes mellitus: Is prevention possible? European
Journal of Endocrinology, 146, 467–477.
Kissebah, A. H., Sonnenberg, G. E., Myklebust, J.,
Goldstein, M., Broman, K., James, R. G., Marks, J. A.,
Krakower, G. R., Jacob, H. J., Weber, J., Martin, L.,
Blangero, J., & Comuzzie, A. G. (2000). Quantitative
trait loci on chromosomes 3 and 17 influence pheno-
types of the metabolic syndrome. Proceedings of the
National Academy of Sciences of the United States of
America, 97, 14478–14483.
Koerner, A., Kratzsch, J., & Kiess, W. (2005). Adipocyto -
kines: leptin—the classical, resistin—the controversical,
adiponectin—the promising, and more to come. Best
Practice and Research: Clinical Endocrinology and
Metabolism, 19, 525–546.
Krosnick, A. (2000). The diabetes and obesity epidemic
among the Pima Indians. New Jersey Medicine, 97,
31–37.
Kulkarni, R. N. (2004). The islet beta-cell. Int J Biochem
Cell Biol, 36, 365–371.
Lander, E., & Kruglyak, L. (1995). Genetic dissection of
complex traits: Guidelines for interpreting and report-
ing linkage results. Nature Genetics, 11, 241–247.
Laukkanen, O., Pihlajamaki, J., Lindstrom, J., Eriksson,
J., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P.,
Keinanen-Kiukaanniemi, S., Tuomilehto, J., Uusitupa,
M., & Laakso, M. (2004). Polymorphisms of the
SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict
the conversion from impaired glucose tolerance to
type 2 diabetes. The Finnish Diabetes Prevention
Study. Journal of Clinical Endocrinology and
Metabolism, 89, 6286–6290.
Lee, P. D., Giudice, L. C., Conover, C. A., & Powell, D.
R. (1997). Insulin-like growth factor binding protein-
1: Recent findings and new directions. Proceedings of
the Society for Experimental Biology and Medicine,
216, 319–357.
Loos, R., Derom, C., Vlietinck, R., & Derom, R. (1998).
The East Flanders Prospective Twin Survey (Belgium):
A population-based register. Twin Research, 1,
167–175.
Loos, R. J., Katzmarzyk, P. T., Rao, D. C., Rice, T., Leon,
A. S., Skinner, J. S., Wilmore, J. H., Rankinen, T., &
Bouchard, C. (2003). Genome-wide linkage scan for
the metabolic syndrome in the HERITAGE Family
Study. Journal of Clinical Endocrinology and
Metabolism, 88, 5935–5943.
Luke, A., Wu, X., Zhu, X., Kan, D., Su, Y., & Cooper, R.
(2003). Linkage for BMI at 3q27 region confirmed in
an African–American population. Diabetes, 52,
1284–1287.
515Twin Research and Human Genetics October 2008
Linkage of Metabolically ‘Thrifty’ Genes in the EFPTS
Meier, U., & Gressner, A. M. (2004). Endocrine regulation
of energy metabolism: Review of pathobiochemical
and clinical chemical aspects of leptin, ghrelin,
adiponectin, and resistin. Clinical Chemistry, 50,
1511–1525.
Menzaghi, C., Ercolino, T., Di Paola, R., Berg, A. H.,
Warram, J. H., Scherer, P. E., Trischitta, V., & Doria,
A. (2002). A haplotype at the adiponectin locus is
associated with obesity and other features of the
insulin resistance syndrome. Diabetes, 51, 2306–2312.
Morley, M., Molony, C. M., Weber, T. M., Devlin, J. L.,
Ewens, K. G., Spielman, R. S., & Cheung, V. G.
(2004). Genetic analysis of genome-wide variation in
human gene expression. Nature, 430, 743–747.
Muoio, D. M., & Lynis Dohm, G. (2002). Peripheral
metabolic actions of leptin. Best Practice and Research:
Clinical Endocrinology and Metabolism, 16, 653–666.
Neale, M. C., Boker, S. M., Xie, G., & Maes, H. H.
(2002). Mx: Statistical Modeling. Richmond, VA:
VCU Department of Psychiatry.
O’Rahilly, S., Barroso, I., & Wareham, N. J. (2005).
Genetic factors in type 2 diabetes: The end of the
beginning? Science, 307, 370–373.
Paracchini, V., Pedotti, P., & Taioli, E. (2005). Genetics of
leptin and obesity: A HuGE review. American Journal
of Epidemiology, 162, 101–114.
Pollin, T. I., Tanner, K., O’Connell, J. R., Ott, S. H.,
Damcott, C. M., Shuldiner, A. R., McLenithan, J. C.,
& Mitchell, B. D. (2005). Linkage of plasma
adiponectin levels to 3q27 explained by association
with variation in the APM1 gene. Diabetes, 54,
268–274.
Qi, L., Doria, A., Manson, J. E., Meigs, J. B., Hunter, D.,
Mantzoros, C. S., & Hu, F. B. (2006). Adiponectin
genetic variability, plasma adiponectin, and cardiovas-
cular risk in patients with type 2 diabetes. Diabetes,
55, 1512–1516.
Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J.,
Argyropoulos, G., Walts, B., Perusse, L., & Bouchard,
C. (2006). The human obesity gene map: The 2005
update. Obesity (Silver Spring), 14, 529–644.
Rea, R., & Donnelly, R. (2004). Resistin: An adipocyte-
derived hormone. Has it a role in diabetes and obesity?
Diabetes Obesity and Metabolism, 6, 163–170.
Saltiel, A. R. (2001). New perspectives into the molecular
pathogenesis and treatment of type 2 diabetes. Cell,
104, 517–529.
Schulz, S., Hackel, C., & Weise, W. (2000). Hormonal
regulation of neonatal weight: Placental leptin and
leptin receptors. BJOG: An International Journal of
Obstetrics and Gynaecology, 107, 1486–1491.
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C.
J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H.
M., Chines, P. S., Jackson, A. U., Prokunina-Olsson,
L., Ding, C. J., Swift, A. J., Narisu, N., Hu, T., Pruim,
R., Xiao, R., Li, X. Y., Conneely, K. N., Riebow, N.
L., Sprau, A. G., Tong, M., White, P. P., Hetrick, K.
N., Barnhart, M. W., Bark, C. W., Goldstein, J. L.,
Watkins, L., Xiang, F., Saramies, J., Buchanan, T. A.,
Watanabe, R. M., Valle, T. T., Kinnunen, L., Abecasis,
G. R., Pugh, E. W., Doheny, K. F., Bergman, R. N.,
Tuomilehto, J., Collins, F. S., & Boehnke, M. (2007).
A genome-wide association study of type 2 diabetes in
Finns detects multiple susceptibility variants. Science,
316, 1341–1345.
Souren, N. Y., Paulussen, A. D., Loos, R. J., Gielen, M.,
Beunen, G., Fagard, R., Derom, C., Vlietinck, R., &
Zeegers, M. P. (2007). Anthropometry, carbohydrate
and lipid metabolism in the East Flanders Prospective
Twin Survey: Heritabilities. Diabetologia, 50,
2107–2116.
Souren, N. Y., Paulussen, A. D. C., Steyls, A., Loos, R. J.
F., Stassen, A. P., Gielen, M., Smeets, H. J., Beunen,
G., Fagard, R., Derom, C., Vlietinck, R., Geraedts, J.
P., & Zeegers, M. P. (2008). Common SNPs in LEP
and LEPR associated with birth weight and type 2 dia-
betes related metabolic risk factors in twins.
International Journal of Obesity, 32, 1233–1239.
Stephens, R. H., McElduff, P., Heald, A. H., New, J. P.,
Worthington, J., Ollier, W. E., & Gibson, J. M.
(2005). Polymorphisms in IGF-binding protein 1 are
associated with impaired renal function in type 2 dia-
betes. Diabetes, 54, 3547–3553.
Sutton, B. S., Weinert, S., Langefeld, C. D., Williams, A.
H., Campbell, J. K., Saad, M. F., Haffner, S. M.,
Norris, J. M., & Bowden, D. W. (2005). Genetic
analysis of adiponectin and obesity in Hispanic fami-
lies: the IRAS Family Study. Human Genetics, 117,
107–118.
Ukkola, O., Sun, G., & Bouchard, C. (2001). Insulin-like
growth factor 2 (IGF2) and IGF-binding protein 1
(IGFBP1) gene variants are associated with overfeed-
ing-induced metabolic changes. Diabetologia, 44,
2231–2236.
Vasseur, F., Meyre, D., & Froguel, P. (2006). Adiponectin,
type 2 diabetes and the metabolic syndrome: Lessons
from human genetic studies. Expert Reviews in Mole -
cular Medicine, 8, 1–12.
Wolk, K., Larsson, S. C., Vessby, B., Wolk, A., & Brismar,
K. (2004). Metabolic, anthropometric, and nutritional
factors as predictors of circulating insulin-like growth
factor binding protein-1 levels in middle-aged and
elderly men. Journal of Clinical Endocrinology and
Metabolism, 89, 1879–1884.
Yan, L., Figueroa, D. J., Austin, C. P., Liu, Y., Bugianesi,
R. M., Slaughter, R. S., Kaczorowski, G. J., & Kohler,
M. G. (2004). Expression of voltage-gated potassium
channels in human and rhesus pancreatic islets.
Diabetes, 53, 597–607. 
516 Twin Research and Human Genetics October 2008
Nicole Y. Souren et al.
